IONIS PHARMACEUT reported $31M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Agios Pharmaceuticals AGIO:US $ 27.15M 2.06M
Alnylam Pharmaceuticals ALNY:US $ 142.07M 11.75M
Arena Pharmaceuticals ARNA:US $ 30.3M 1.63M
Astellas Pharma 4503:JP 133.4B 3.71B
Biocryst Pharmaceuticals BCRX:US $ 34.99M 8.67M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Bluebird Bio BLUE:US $ 68.28M 10.3M
Dicerna Pharmaceuticals DRNA:US $ 21.99M 3.47M
Esperion Therapeutics ESPR:US $ 39.26M 7.05M
Exelixis EXEL:US $ 101.56M 3.06M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Halozyme Therapeutics HALO:US $ 13.17M 848K
Intercept Pharmaceuticals ICPT:US $ 53.34M 4.32M
Mirati Therapeutics MRTX:US $ 35.18M 5.57M
Moderna Inc MRNA:US 168M 47M
Nektar Therapeutics NKTR:US $ 29.47M 87K
Neurocrine Biosciences NBIX:US $ 154.6M 11.4M
Novartis NOVN:VX 3.6B 109M
Omeros OMER:US $ 20.86M 699K
Pfizer PFE:US $ 2.73B 61M
Ptc Therapeutics PTCT:US $ 69.25M 374K
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M
Sarepta Therapeutics SRPT:US $ 61.13M 11.22M
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M